Literature DB >> 9639341

Rapid modulation of L-type calcium current by acutely applied oestrogens in isolated cardiac myocytes from human, guinea-pig and rat.

R Meyer1, K W Linz, R Surges, S Meinardus, J Vees, A Hoffmann, O Windholz, C Grohé.   

Abstract

Gender-based differences in cardiovascular mortality may be due to a cardio-protective effect of oestrogens on the myocardium. However, mRNA expression of oestrogen receptors in myocardial tissue of the adult heart has yet to be demonstrated. Furthermore, a calcium antagonistic action of 17beta-oestradiol on myocardial tissue has been discussed. Therefore, two subjects were investigated in atrial myocytes of the human, and ventricular myocytes of guinea-pig and rat in this study. (1) Are oestrogen receptors expressed in adult myocardial cells? (2) Is there an influence of oestrogens on the L-type calcium current of cardiac myocytes? Expression of oestrogen receptors was investigated by reverse polymerase chain reaction. L-type calcium current was usually measured by the patch-clamp technique in whole-cell recording mode under selective recording conditions, i.e. overlapping currents were blocked. One series of experiments was performed in perforated patch configuration to avoid internal perfusion. 17beta-oestradiol inhibited L-type calcium current reversibly in all three species. At 10(-5) M, the inhibition was 15-20%. This inhibition was independent of the sex and the species. A full concentration response curve of 17beta-oestradiol on basal L-type current was recorded from female guinea-pig myocytes. The inhibition increased from 2% at 10(-7) M to about 30% at 10(-4) M 17beta-oestradiol. The values could be fitted by a sum of two sigmoidal functions with log EC50 values of -6.5 and -4.9 M and Hill slopes of 2.5 for both. The specificity of the 17beta-oestradiol action was tested by recording the L-type current in the presence of 17alpha-oestradiol and oestrone. 17alpha-oestradiol also inhibited the current, but with a maximal inhibition of only 17%. The concentration-response curve could be fitted by a single sigmoidal function (log EC50 -6-3 M; Hill slope 0.55). Oestrone did not influence the current at all. The decrease in L-type current after the application of 17beta-oestradiol via a rapid perfusion system developed with a time constant of 3-4 s, which was in the same range as that for the influence of isoprenaline. The isoprenaline-stimulated L-type current was much more susceptible to the inhibition by 17beta-oestradiol, i.e. in pre-stimulated cells (1) the inhibitory effect is significantly higher (e.g. at 10(-5) M, inhibition was 36.3% compared with 11.2% in untreated cells) and (2) an inhibitory effect can be seen with oestradiol concentrations as low as 10(-9) M. Although the concentrations needed to gain a calcium antagonistic influence on the basal current were much too high to explain a cardio-protective influence of oestrogens, the presence of oestrogen receptors in cardiac myocytes of all three species, together with the shift in concentration dependence following pre-stimulation by isoprenaline, suggest that myocytes are a potential target for oestrogen.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9639341     DOI: 10.1113/expphysiol.1998.sp004115

Source DB:  PubMed          Journal:  Exp Physiol        ISSN: 0958-0670            Impact factor:   2.969


  18 in total

1.  Rapid estrogen receptor-mediated mechanisms determine the sexually dimorphic sensitivity of ventricular myocytes to 17β-estradiol and the environmental endocrine disruptor bisphenol A.

Authors:  Scott M Belcher; Yamei Chen; Sujuan Yan; Hong-Sheng Wang
Journal:  Endocrinology       Date:  2011-12-13       Impact factor: 4.736

2.  Effects of gender difference on cardiac myocyte dysfunction in streptozotocin-induced diabetic rats.

Authors:  Yanfeng Ding; Ruijiao Zou; Robert L Judd; Juming Zhong
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

3.  Greater antiarrhythmic activity of acute 17beta-estradiol in female than male anaesthetized rats: correlation with Ca2+ channel blockade.

Authors:  K L Philp; M Hussain; N F Byrne; M J Diver; G Hart; S J Coker
Journal:  Br J Pharmacol       Date:  2006-08-29       Impact factor: 8.739

4.  A novel steroid-like compound F90927 exerting positive-inotropic effects in cardiac muscle.

Authors:  Christophe Pignier; Markus Keller; Bruno Vié; Bernard Vacher; Maurice Santelli; Ernst Niggli; Marcel Egger; Bruno Le Grand
Journal:  Br J Pharmacol       Date:  2006-04       Impact factor: 8.739

5.  Acute exposure to progesterone attenuates cardiac contraction by modifying myofilament calcium sensitivity in the female mouse heart.

Authors:  Hirad A Feridooni; Jennifer K MacDonald; Anjali Ghimire; W Glen Pyle; Susan E Howlett
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-10-28       Impact factor: 4.733

6.  Oestrogen upregulates L-type Ca²⁺ channels via oestrogen-receptor- by a regional genomic mechanism in female rabbit hearts.

Authors:  Xiaoyan Yang; Guojun Chen; Rita Papp; Donald B Defranco; Fandian Zeng; Guy Salama
Journal:  J Physiol       Date:  2011-11-28       Impact factor: 5.182

7.  Sexual dimorphism in rat left atrial function and response to adrenergic stimulation.

Authors:  D W Schwertz; V Vizgirda; R J Solaro; M R Piano; C Ryjewski
Journal:  Mol Cell Biochem       Date:  1999-10       Impact factor: 3.396

8.  The effect of deoxygenation on whole-cell conductance of red blood cells from healthy individuals and patients with sickle cell disease.

Authors:  Joseph A Browning; Henry M Staines; Hannah C Robinson; Trevor Powell; J Clive Ellory; John S Gibson
Journal:  Blood       Date:  2006-11-30       Impact factor: 22.113

9.  Raloxifene acutely suppresses ventricular myocyte contractility through inhibition of the L-type calcium current.

Authors:  Reginald Liew; Mark A Stagg; Kenneth T MacLeod; Peter Collins
Journal:  Br J Pharmacol       Date:  2004-03-15       Impact factor: 8.739

Review 10.  Androgen receptor (AR) in cardiovascular diseases.

Authors:  Chiung-Kuei Huang; Soo Ok Lee; Eugene Chang; Haiyan Pang; Chawnshang Chang
Journal:  J Endocrinol       Date:  2016-01-14       Impact factor: 4.286

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.